Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - Report of three cases

European Journal of Haematology

Volumn 74, Issue 3, 2005, Pages 250-253

  Kornacker, M ^a   Luft, T ^a   Ho, A D ^a   Schaefer, H J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Endothelial damage; Multiple myeloma; Stem cell transplantation; Thrombotic microangiopathy

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IDARUBICIN; MELPHALAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THALIDOMIDE; VINCRISTINE;

ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ALLOGRAFT; ARTICLE; AUTOGRAFT; CASE REPORT; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG MEGADOSE; ENDOTHELIUM INJURY; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; NONMYELOABLATIVE CONDITIONING; PATHOGENESIS; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; THROMBOTIC THROMBOCYTOPENIC PURPURA; WHOLE BODY RADIATION;

ANTINEOPLASTIC AGENTS; ENDOTHELIUM, VASCULAR; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RADIOTHERAPY, ADJUVANT; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 14044262202     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00372.x     Document Type: Article

References (10)

1. PETTITT AR, CLARK RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994;14:495-504.
2. ZEIGLER ZR, SHADDOCK RK, NEMUNAITIS J, ANDREWS DF, ROSENFELD CS. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995;15:247-253.
3. IACOPINO P, PUCCI G, ARCESE W, et al. Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO). Bone Marrow Transplant 1999;24:47-51.
4. RUUTU T, HERMANS J, NIEDERWIESER D, et al. Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European group for blood and marrow transplantation (EBMT). Br J Haematol 2002;118:1112-1119.
5. FASSAS AB, BUDDHARAJU LN, RAPOPORT A, COTTLER-FOX M, DRACHENBERG C, MEISENBERG B, TRICOT G. Fatal disseminated adenoviral infection associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation. Leuk Lymphoma 2001;42:801-804.
6. PETERSEN SL, MADSEN HO, RYDER LP, SVEJGAARD A, JAKOBSEN BK, SENGELOV H, HEILMANN C, DICKMEISS E, VINDELOV LL. Haematopoietic stem cell transplantation with non-myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution. Br J Haematol 2004;125:225-231.
7. SHIMONI A, YESHURUN M, HARDAN I, AVIGDOR A, BEN BASSAT I, NAGLER A. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: the incidence is not reduced. Biol Blood Marrow Transplant 2004;10:484-493.
8. HOBSON B, DENEKAMP J. Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br J Cancer 1984;49:405-413.
9. EISSNER G, MULTHOFF G, GERBITZ A, KIRCHNER S, BAUER S, HAFFNER S, SONDERMANN D, ANDREESEN R, HOLLER E. Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood 2002;100:334-340.
10. CORTI P, UDERZO C, TAGLIABUE A, DELLA VOLPE A, ANNALORO C, TAGLIAFERRI E, BALDUZZI A. Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation. Bone Marrow Transplant 2002;29:542-543.